Does combination therapy work in chronic thromboembolic pulmonary hypertension?
Objective: The current experience with combination therapy in chronic thromboembolic pulmonary hypertension (CTEPH) is limited. We present the first survival results up to 5 years for dual combination therapy versus monotherapy in CTEPH. Methods: All consecutive, non-operated CTEPH or residual PH af...
Main Authors: | M.C.J. van Thor, R.J. Snijder, J.C. Kelder, J.J. Mager, M.C. Post |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | International Journal of Cardiology: Heart & Vasculature |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906720301408 |
Similar Items
-
Monotherapy in patients with pulmonary arterial hypertension at four German PH centres
by: Beate Stubbe, et al.
Published: (2021-04-01) -
Incidence of chronic thromboembolic pulmonary hypertension in Thammasat University Hospital
by: Suphathat Puengpapat, et al.
Published: (2018-01-01) -
Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension
by: M.C.J. van Thor, et al.
Published: (2019-03-01) -
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: NEW ASPECTS OF THE DEVELOPMENT AND PROGRESSION OF THE DISEASE
by: A. A. Klimenko, et al.
Published: (2014-07-01) -
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: NEW ASPECTS OF THE DEVELOPMENT AND PROGRESSION OF THE DISEASE
by: A. A. Klimenko, et al.
Published: (2014-07-01)